Each year, Becker’s Healthcare recognizes the medical community’s top patient safety experts. The clinicians, researchers and healthcare experts highlighted are fierce advocates for safety and prioritize improving patient care in every facet of their professional careers. This year, we're incredibly proud to see Glytec represented on such a prestigious list – our Chief Medical Officer (CMO) Dr. Jordan Messler was recognized as one of the 26 patient safety experts to know in 2022.
Dr. Messler encapsulates Glytec’s patient-first focus in every initiative he leads at our company. We’re honored to have him at the helm of our clinical team, driving continuous improvement initiatives and supporting the delivery, customer, quality, and regulatory teams to ensure ethical and safe glycemic management best practices. Dr. Messler is also a champion of product innovation and works closely with our product and clinical teams enhancing our software and being the patient safety and physician advocate at various steps of development.
As the National Committee Chair for the SMH Quality and Patient Safety Forum, frequent peer-reviewed contributor, and regular hospital and industry lecturer, it's easy to see why Becker's added Dr. Messler to the 2022-2023 list.
But it's what Dr. Messler does day in and out for our teammates, partners and customers that makes his work so impactful. Hear what some of his colleagues and our customers have to say:
As highlighted by his colleagues, Dr. Messler is a key resource to us at Glytec, our customer partners, and leads by example with his approach to patient safety. Hear about inpatient best practices and our patient-centric philosophy around glycemic management directly from Dr. Messler and his co-presenter, the University of Nebraska Medical Center’s Medical Director of Diabetes and Endocrinology Center, Dr. Andjela Drincic here.
©Copyright 2023 Glytec, LLC on behalf of Aseko, Inc. | Terms of Use | Legal Disclaimer | Privacy Policy | Contraindications, Warnings and Precautions
The eGlycemic Management System® is a modularized solution for glycemic management across the care continuum that includes Glucommander™. Glucommander™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.
Glucommander™ is only available for use in the United States.
This site is only intended for use in the United States.
Aseko is a registered trademark of Aseko, Inc.